Literature DB >> 18976752

Long-term consequences of polycystic ovary syndrome on cardiovascular risk.

Manfredi Rizzo1, Kaspar Berneis, Giatgen Spinas, Giovam Battista Rini, Enrico Carmina.   

Abstract

Most available data suggest that the prevalence of cardiovascular diseases in women with polycystic ovary syndrome (PCOS) is smaller than expected based on risk calculations during fertile years; therefore, more studies are needed on long-term cardiovascular consequences. Evidence is accumulating that postmenopausal women with PCOS have an increased risk of cerebrovascular events and cardiovascular morbidity. These events are partially related to persisting hyperandrogenism but are mostly correlated with excessive body weight (mainly visceral obesity); this suggests that our best long-term strategy is to ensure that women with PCOS are informed about their high risk for metabolic and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976752     DOI: 10.1016/j.fertnstert.2008.09.070

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

1.  Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome.

Authors:  M Rizzo; R A Longo; E Guastella; G B Rini; E Carmina
Journal:  J Endocrinol Invest       Date:  2010-10-15       Impact factor: 4.256

2.  Long term health consequences of polycystic ovarian syndrome: a review analysis.

Authors:  A Daniilidis; K Dinas
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

Review 3.  Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens.

Authors:  Licy L Yanes Cardozo; Damian G Romero; Jane F Reckelhoff
Journal:  Physiology (Bethesda)       Date:  2017-09

Review 4.  Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.

Authors:  Héctor F Escobar-Morreale; Manuel Luque-Ramírez; Frank González
Journal:  Fertil Steril       Date:  2010-12-17       Impact factor: 7.329

Review 5.  Importance of engaging obstetrician/gynecologists in cardiovascular disease prevention.

Authors:  Deborah B Ehrenthal; Janet M Catov
Journal:  Curr Opin Cardiol       Date:  2013-09       Impact factor: 2.161

6.  Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials.

Authors:  Vittorio Unfer; Fabio Facchinetti; Beatrice Orrù; Barbara Giordani; John Nestler
Journal:  Endocr Connect       Date:  2017-11       Impact factor: 3.335

7.  Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome.

Authors:  Mariona Jové; Irene Pradas; Alba Naudí; Susana Rovira-Llopis; Celia Bañuls; Milagros Rocha; Manuel Portero-Otin; Antonio Hernández-Mijares; Victor M Victor; Reinald Pamplona
Journal:  Oncotarget       Date:  2017-12-17

8.  Association of Age of Metabolic Syndrome Onset With Cardiovascular Diseases: The Kailuan Study.

Authors:  Zegui Huang; Xianxuan Wang; Xiong Ding; Zefeng Cai; Weijian Li; Zekai Chen; Wei Fang; Zhiwei Cai; Yulong Lan; Guanzhi Chen; Weiqiang Wu; Zhichao Chen; Shouling Wu; Youren Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-17       Impact factor: 5.555

9.  Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.

Authors:  Yue Zhao; Li Fu; Rong Li; Li-Na Wang; Yan Yang; Na-Na Liu; Chun-Mei Zhang; Ying Wang; Ping Liu; Bin-Bin Tu; Xue Zhang; Jie Qiao
Journal:  BMC Med       Date:  2012-11-30       Impact factor: 8.775

10.  Circulating SCUBE1 levels in women with polycystic ovary syndrome.

Authors:  Onur Erol; Hamit Yaşar Ellidağ; Mustafa Kemal Özel; Aysel Uysal Derbent; Esin Eren; Necat Yılmaz
Journal:  Turk J Obstet Gynecol       Date:  2018-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.